Advertisement
Research Article

Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development

  • Rolando Pajon,

    Affiliation: Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America

    X
  • Andrew M. Fergus,

    Affiliation: Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America

    X
  • Oliver Koeberling,

    Affiliation: Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America

    Current address: Novartis Vaccine Institute for Global Health, Siena, Italy

    X
  • Dominique A. Caugant,

    Affiliation: Department of Bacteriology and Immunology, Norwegian Institute of Public Health, and Department of Community Medicine, University of Oslo, Oslo, Norway

    X
  • Dan M. Granoff mail

    dgranoff@chori.org

    Affiliation: Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America

    X
  • Published: September 06, 2011
  • DOI: 10.1371/journal.pntd.0001302

About the Authors

Rolando Pajon, Andrew M. Fergus, Oliver Koeberling, Dan M. Granoff
Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, Oakland, California, United States of America
Dominique A. Caugant
Department of Bacteriology and Immunology, Norwegian Institute of Public Health, and Department of Community Medicine, University of Oslo, Oslo, Norway

Corresponding Author

Email: dgranoff@chori.org

Competing Interests

Dan M. Granoff is principal investigator of laboratory research conducted on behalf of Children's Hospital Oakland Research Institute that is funded by grants from Novartis Vaccines and Diagnostics, and Sanofi Pasteur. He also holds a paid consultancy from Novartis. Dominique A. Caugant has performed research at the Norwegian Institute of Public Health funded by Novartis, Wyeth and Sanofi Pasteur. Oliver Koeberling is currently an employee of Novartis Vaccine Institute for Global Health, Siena Italy. Rolando Pajon and Andrew M. Fergus declare no conflicts.

Author Contributions

Conceived and designed the experiments: RP DAC DMG. Performed the experiments: RP AMF OK. Analyzed the data: RP DMG. Contributed reagents/materials/analysis tools: DAC. Wrote the paper: RP DMG.